The cellular origins of drug resistance in cancer

Nat Med. 2016 Mar;22(3):232-4. doi: 10.1038/nm.4058.

Author

Geoffrey R Oxnard¹

Affiliation

¹ Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.

PMID: 26937615
DOI: 10.1038/nm.4058

No abstract available

MeSH terms

Antineoplastic Agents / therapeutic use
Carcinoma, Non-Small-Cell Lung / drug therapy
Carcinoma, Non-Small-Cell Lung / genetics*
Cell Line, Tumor
Drug Resistance, Neoplasm / genetics*
ErbB Receptors / antagonists & inhibitors*
Genes, erbB-1*
Humans
Lung Neoplasms / drug therapy
Lung Neoplasms / genetics*
Molecular Targeted Therapy
Mutation
Protein Kinase Inhibitors / therapeutic use

Substances

Antineoplastic Agents
Protein Kinase Inhibitors
ErbB Receptors